Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Latin America COVID-19 Diagnostics Market: By Test Type: PCR Test, Antigen Test, Antibody Test, Others; By Product; By Sample Type: Nasopharyngeal Swab, Oropharyngeal (OP) Swab, Nasal Swab, Blood Test, Others; By Business Model; By End Use; By Country (2020-2026); Competitive Landscape, 2021-2026

Latin America COVID-19 Diagnostics Market Outlook

The Latin America COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in Brazil, which has performed around 29 million tests for COVID-19 as of March 2021.

 

Latin America COVID-19 Diagnostics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Demand for  PCR-based Diagnosis to Augment the COVID-19 Diagnostics Industry Growth in Latin America

Based on test type, the PCR test segment accounts for a significant share in the industry. Currently, the PCR technique is thought to be the most effective for detecting COVID-19, resulting in a massive rise in the use of PCR research kits. Laboratories, hospitals, medical centres and clinics, and research institutes favour the PCR approach for identification over others because of its advantages. PCR is perhaps the most important molecular technique ever devised. Since it eliminated the need for post-reaction manipulation, real-time quantitative PCR (qPCR) revolutionised the clinical implementation of PCR. While qPCR has been around for over two decades, it has only been used in clinical environments, where other approaches are not feasible, such as tracking therapy in diseases like chronic-phase chronic myeloid leukaemia, or for a few main blood-borne viruses.

Many organisations have begun designing PCR-based diagnostic testing for efficient diagnosis as the number of COVID-19 cases grows exponentially across the world. More than 100 PCR-based diagnostic tests were licenced or are in the development process for clinical use as of May 2020. This high number suggests this technology's market superiority, thus, resulting in a strong sales share for this segment over the projected era.

 

Brazil to Provide Enhanced Growth Opportunities to the Latin America COVID-19 Diagnostics Industry

Brazil is likely to emerge as a viable growth ground for the COVID-19 diagnostics industry on a regional level due to the highest number of tests done in the world. Brazil has been drastically hit by the pandemic with around a quarter million deaths in the past year. With the second wave incoming, Brazil is witnessing a sudden surge, which is expected to be far worse than the first wave, thus, increasing the demand for COVID-19 testing kits. Even though the number of cases is on a constant decline in rest of the world, the Brazilian market will continue to grow.

In rest of Latin America, the demand seems to be growing with time due to lack of resources and the presence of large number of low-income families. Countries like Argentina, Chile, and Peru are expected to observe a high rate of growth in the forecast period.

 

COVID-19 Diagnostics: Industry Definition and Segmentation

COVID-19 research and diagnostic entails processing samples to determine if SARS-CoV-2 is present or has been present in the past. The virus or the antibodies formed in response to infection are detected by the two main branches. Molecular tests for viral presence based on the molecular components are used to detect specific patients as well as to help public health officials track down and control outbreaks. Antibody examinations (serology immunoassays) are used to determine if a person has ever had the disease. Since antibodies may not mature until weeks after diagnosis, they are less effective for diagnosing current infections. It is used to figure out how common an illness is, which helps in estimating the infection fatality risk.

 

Latin America COVID-19 Diagnostics Market By End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By test type, the market is classified into:

  • PCR Test     
  • Antigen Test
  • Antibody Test
  • Others

The market is divided based on product into:

  • RT-PCR Assay Kits
  • Immunoassay Test Strips
  • Others

The market is segmented based on sample type into:

  • Nasopharyngeal Swab
  • Oropharyngeal (OP) Swab
  • Nasal Swab
  • Blood Test
  • Others

On the basis of business model, the market can be categorised into:

  • Point-of-Care (PoC) Testing
  • Non-Point-of-Care (PoC) Testing

Based on end use the market is classified into:

  • Hospitals
  • Diagnostic Centres and Clinics   
  • Laboratories   
  • Others   

The regional markets for the product include Brazil, Mexico, Argentina, and Colombia, among other countries.

 

Latin America COVID-19 Diagnostics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Number of COVID-19 Cases and Rise in Travel to Bolster the Growth of the Latin America COVID-19 Diagnostics Industry

Since the advent of COVID-19, Latin America has suffered the most due to lack of healthcare facilities and weak government laws, which led to a staggering increase in the number of cases in the first few months. Due to the high number of cases, the government had to perform the tests at a fast pace but due to lack of healthcare facilities, the countries such as Brazil had to import a large number of COVID-19 testing kits from other countries like the United States and China. To ensure that the number of deaths are controlled along with the spread, rapid testing became the go to testing method. This led to a rise in demand for COVID-19 testing kits in the region. Apart from the population of Latin America, people who travel to the continent need to get tested too, which is expected to support the growth of the market positively. The market is expected to grow for a while as there is no knowing when the pandemic will end, and as things are going the number of cases is exponentially increasing in Latin America.

 

Key Industry Players in the Latin America COVID-19 Diagnostics Market

The report gives a detailed analysis of the following key players in the Latin America COVID-19 diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • F. Hoffmann -La Roche Ltd
  • Mobius Life Science
  • Co-Diagnostics, Inc 
  • Bioinnovo
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Test Type, Product, Sample Type, Business Model, End Use, Country
Breakup by Test Type PCR Test, Antigen Test, Antibody Test, Others
Breakup by Product RT-PCR Assay Kits, Immunoassay Test Strips, Others
Breakup by Sample Type Nasopharyngeal Swab, Oropharyngeal (OP) Swab, Nasal Swab, Blood Test, Others
Breakup by Business Model Point-of-Care (PoC) Testing, Non-Point-of-Care (PoC) Testing
Breakup by End Use Hospitals, Diagnostic Centres and Clinics, Laboratories, Others
Breakup by Country Brazil, Mexico, Argentina, Colombia, Others
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered F. Hoffmann -La Roche Ltd, Mobius Life Science, Co-Diagnostics, Inc Bioinnovo, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Latin America
7    Industry Opportunities and Challenges
8    Latin America Covid-19 Overview

    8.1    Key Industry Highlights
    8.2    Number of Covid-19 Cases in Latin America
    8.3    Latin America Covid-19 Cases by Region
        8.3.1    Brazil
        8.3.2    Mexico
        8.3.3    Argentina
        8.3.4    Colombia
        8.3.5    Others
9    Latin America COVID-19 Diagnostics Market Analysis
    9.1    Key Industry Highlights
    9.2    Latin America COVID-19 Diagnostics Market (2020-2026) 
    9.3    Latin America COVID-19 Diagnostics Market by Test Type (2020-2026)
        9.3.1    PCR Test
        9.3.2    Antigen Test
        9.3.3    Antibody Test
        9.3.4    Others
    9.4    Latin America COVID-19 Diagnostics Market by Product (2020-2026)
        9.4.1    RT-PCR Assay Kits
        9.4.2    Immunoassay Test Strips
        9.4.3    Others
    9.5    Latin America COVID-19 Diagnostics Market by Sample Type (2020-2026)
        9.5.1    Nasopharyngeal Swab
        9.5.2    Oropharyngeal (OP) Swab
        9.5.3    Nasal Swab
        9.5.4    Blood Test
        9.5.5    Others
    9.6    Latin America COVID-19 Diagnostics Market by Business Model (2020-2026)
        9.6.1    Point-of-Care (PoC) Testing
        9.6.2    Non-Point-of-Care (PoC) Testing
    9.7    Latin America COVID-19 Diagnostics Market by End Use (2020-2026)
        9.7.1    Hospitals
        9.7.2    Diagnostic Centres and Clinics   
        9.7.3    Laboratories
        9.7.4    Others
    9.8    Latin America COVID-19 Diagnostics Market by Country (2020-2026)
        9.8.1    Brazil
        9.8.2    Mexico  
        9.8.3    Argentina
        9.8.4    Colombia
        9.8.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    F. Hoffmann-La Roche Ltd
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Mobius Life Science
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Co-Diagnostics, Inc 
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Bioinnovo
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Others
12    Industry Events and Developments


List of Figures and Tables

1.    Latin America COVID-19 Cases by Country
2.    Latin America COVID-19 Diagnostics Market: Key Industry Highlights, 2020 and 2026
3.    Latin America COVID-19 Diagnostics Market: Breakup by Test Type (USD Billion)
4.    Latin America COVID-19 Diagnostics Market: Breakup by Product (USD Billion)
5.    Latin America COVID-19 Diagnostics Market: Breakup by Sample Type (USD Billion)
6.    Latin America COVID-19 Diagnostics Market: Breakup by Business Model (USD Billion)
7.    Latin America COVID-19 Diagnostics Market: Breakup by End Use (USD Billion)
8.    Latin America COVID-19 Diagnostics Market: Breakup by Country (USD Billion), 
9.    Latin America COVID-19 Diagnostics Market Structure

Key Questions Answered in the Report

The Latin America COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in Brazil, which has performed around 29 million tests for COVID-19 as of March 2021.

The major drivers of the industry, such as the rising research and development activities, increasing cases of COVID-19, rise in travel, and favourable government policies, are aiding the market growth.

The key market trend guiding the growth of the industry includes the growing technological advancements.

The major regions in the industry are Brazil, Mexico, Argentina, and Colombia, among others. 

The major test types available in the industry are PCR test, antigen test, and antibody test, among others.

The major products available in the industry are RT-PCR assay kits, and immunoassay test strips, among others.

The sample types available in the market are nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others.

The significant business models are point-of-care (PoC) testing and non-point-of-care (PoC) testing.

The significant end users are hospitals, diagnostic centres and clinics, and laboratories, among others.

The major players in the industry are F. Hoffmann -La Roche Ltd, Mobius Life Science, Co-Diagnostics, Inc, and Bioinnovo, among others.

Analyst Review

The Latin America COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in Brazil, which has performed around 29 million tests for COVID-19 as of March 2021.The market is being aided by the favourable government policies and rise in funding for R&D in this field.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its test types, the COVID-19 diagnostics industry can be segmented into PCR test, antigen test, antibody test, and others. On the basis of products, the industry is divided into RT-PCR assay kits, and immunoassay test strips, among others. By sample types, the industry is categorised into nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others. On the basis of business models, the industry is bifurcated into point-of-care (PoC) testing and non-point-of-care (PoC) testing. Based on end users, the industry is segregated into hospitals, diagnostic centres and clinics, and laboratories, among others. The major regional markets for COVID-19 diagnostics in Latin America are Brazil, Mexico, Argentina, and Colombia, among others. The key players in the above market include F. Hoffmann -La Roche Ltd, Mobius Life Science, Co-Diagnostics, Inc, and Bioinnovo, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER